Remicade Biosimilar Market By Type | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Remicade Biosimilar Market
Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region - Forecast(2018 - 2023)
Report Code : HCR 0368
Updated Date: 15 May, 2018  

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
1. Remicade Biosimilar Market – Market Overview
2. Executive Summary 
3. Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Remicade Biosimilar Market– Market Forces
   4.1. Drivers
      4.1.1. Development of efficient and advance technology
      4.1.2. Higher expiration patent
   4.2. Restraints
      4.2.1. Higher cost of research and development 
   4.3. Opportunities
      4.3.1. Emerging economies
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Remicade Biosimilar Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Remicade Biosimilar Market, By Type
   6.1. Recombinant Non-Glycosylated Protein
   6.2. Recombinant Glycosylated Protein
   6.3. Peptides
7. Remicade Biosimilar Market, By Technology
   7.1. Monoclonal Antibodies (MAb) Technology
   7.2. Recombinant DNA Technology (rDNA Technology)
   7.3. Nuclear magnetic resonance (NMR) Technology
   7.4. Chromatography
   7.5. Electrophoresis
   7.6. Mass Spectrometry
   7.7. Western Blotting
   7.8. Bioassay
8. Remicade Biosimilar Market, By Service
   8.1. Contract Research and Manufacturing Services (CRAMS)
   8.2. Clinical Trials
9. Remicade Biosimilar Market, By Application 
   9.1. Blood Disorders
   9.2. Oncology Diseases
   9.3. Chronic and Autoimmune Diseases
   9.4. Growth Hormone Deficiencies
   9.5. Others
10. Remicade Biosimilar Market, By Geography
   10.1. Europe
      10.1.1. Germany
      10.1.2. France
      10.1.3. Italy
      10.1.4. Spain
      10.1.5. Russia
      10.1.6. U.K.
      10.1.7. Rest of Europe
   10.2. Asia Pacific
      10.2.1. China
      10.2.2. India
      10.2.3. Japan
      10.2.4. South Korea
      10.2.5. Rest of Asia-Pacific
   10.3. North America 
      10.3.1. U.S.
      10.3.2. Canada
      10.3.3. Mexico
   10.4. Rest of the World (RoW)
      10.4.1. Brazil
      10.4.2. Rest of RoW
11. Remicade Biosimilar – Market Entropy
   11.1. Expansion
   11.2. Technological Developments
   11.3. Merger & Acquisitions, and Joint Ventures
   11.4. Supply- Contract
12. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   12.1. Teva Pharmaceutical Industries Ltd.
   12.2. Synthon Pharmaceuticals, Inc.
   12.3. LG Life Sciences
   12.4. Novartis (Sandoz)
   12.5. Celltrion
   12.6. Biocon
   12.7. Hospira
   12.8. Merck Serono (Merck Group)
   12.9. Biogen idec Inc.
   12.10. Genentech (Roche Group)
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
13. Appendix
   13.1. Abbreviations
   13.2. Sources
   13.3. Research Methodology
   13.4. Bibliography
   13.5. Compilation of Expert Insights
   13.6. Disclaimer
Remicade biosimilar market globally being driven by primary factors like development of efficient and advance technology, higher expiration patent, rise in the awareness among people regarding remicade biosimilar, increasing government initiative across the globe, growing prevalence of chronic diseases among aging population. In addition, increase in adoption of remicade biosimilar in emerging economies such as China, India and others, will create new opportunities for global remicade biosimilar market. However, higher cost of the research and development, and stringent government regulations are the key restraints for global remicade biosimilar market.

Globally, development of efficient and advance technology, higher expiration patent, rise in the awareness among people regarding remicade biosimilar, increasing government initiative across the globe, growing prevalence of chronic diseases among aging population are the prime growth drivers of global remicade biosimilar market. In addition, increase in adoption of remicade biosimilar in emerging economies such as China, India and others, will create new opportunities for global remicade biosimilar market. However, higher cost of the research and development, and stringent government regulations are the key restraints for global remicade biosimilar market.

 Remicade Biosimilar Market

Geographically European dominated global remicade biosimilar market because of favourable regulatory policies designed by the European Medical Association, high medical reimbursement facilities, and technological advancement. Asia Pacific is projected to have fastest growth, owing to rapidly increasing aging population, rise in consumer awareness, favourable government policies, modernization of healthcare infrastructure, and growing prevalence of chronic diseases in developing nations such as China, and India in this region. Among all the application, oncology segment has the highest market share in global remicade biosimilar market due to higher prevalence of cancer patients.

This report identifies the global remicade biosimilar market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global remicade biosimilar market.

This report segments global remicade biosimilar market on the basis of type, technology, service, application, and regional market as follows:
  • Remicade Biosimilar Market, By Type: Recombinant Non-Glycosylated Protein, Recombinant Glycosylated Protein, and Peptides
  • Remicade Biosimilar Market, By Technology: Monoclonal Antibodies (MAb) Technology, Recombinant DNA Technology (rDNA), Nuclear Magnetic Resonance (NMR) Technology, Chromatography, Electrophoresis, Mass Spectrometry, Western Blotting, and Bioassay
  • Remicade Biosimilar Market, By Service: Contract Research and Manufacturing Services (CRAMS), and Clinical Trials
  • The report has focused study on remicade biosimilar market by basis of application such as: Blood Disorders, Oncology Diseases, Chronic and Autoimmune Diseases, Growth Hormone Deficiencies, and Others
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the remicade biosimilar market. Some of the major companies’ profiles in detail are as follows:
  • Teva Pharmaceutical Industries Ltd.
  • Synthon Pharmaceuticals, Inc.
  • LG Life Sciences
  • Novartis (Sandoz)
  • Celltrion
List of Tables:

Table 1: Remicade Biosimilar Market Overview 2017-2023
Table 2: Remicade Biosimilar Market Leader Analysis 2017-2018 (US$)
Table 3: Remicade Biosimilar Market Product Analysis 2017-2018 (US$)
Table 4: Remicade Biosimilar Market End User Analysis 2017-2018 (US$)
Table 5: Remicade Biosimilar Market Patent Analysis 2013-2018* (US$)
Table 6: Remicade Biosimilar Market Financial Analysis 2017-2018 (US$)
Table 7: Remicade Biosimilar Market Driver Analysis 2017-2018 (US$)
Table 8: Remicade Biosimilar Market Challenges Analysis 2017-2018 (US$)
Table 9: Remicade Biosimilar Market Constraint Analysis 2017-2018 (US$)
Table 10: Remicade Biosimilar Market Supplier Bargaining Power Analysis 2017-2018 (US$)
Table 11: Remicade Biosimilar Market Buyer Bargaining Power Analysis 2017-2018 (US$)
Table 12: Remicade Biosimilar Market Threat of Substitutes Analysis 2017-2018 (US$)
Table 13: Remicade Biosimilar Market Threat of New Entrants Analysis 2017-2018 (US$)
Table 14: Remicade Biosimilar Market Degree of Competition Analysis 2017-2018 (US$)
Table 15: Remicade Biosimilar Market Value Chain Analysis 2017-2018 (US$)
Table 16: Remicade Biosimilar Market Pricing Analysis 2018-2023 (US$)
Table 17: Remicade Biosimilar Market Opportunities Analysis 2018-2023 (US$)
Table 18: Remicade Biosimilar Market Product Life Cycle Analysis 2018-2023 (US$)
Table 19: Remicade Biosimilar Market Supplier Analysis 2017-2018 (US$)
Table 20: Remicade Biosimilar Market Distributor Analysis 2017-2018 (US$)
Table 21: Remicade Biosimilar Market Trend Analysis 2017-2018 (US$)
Table 22: Remicade Biosimilar Market Size 2017 (US$)
Table 23: Remicade Biosimilar Market Forecast Analysis 2018-2023 (US$)
Table 24: Remicade Biosimilar Market Sales Forecast Analysis 2018-2023 (Units)
Table 25: Remicade Biosimilar Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 26: Remicade Biosimilar Market By Type, Revenue & Volume, By Recombinant Non-Glycosylated Protein, 2018-2023 ($)
Table 27: Remicade Biosimilar Market By Type, Revenue & Volume, By Recombinant Glycosylated Protein, 2018-2023 ($)
Table 28: Remicade Biosimilar Market By Type, Revenue & Volume, By Peptides, 2018-2023 ($)
Table 29: Remicade Biosimilar Market, Revenue & Volume, By Service, 2018-2023 ($)
Table 30: Remicade Biosimilar Market By Service, Revenue & Volume, By Contract Research and Manufacturing Services (CRAMS), 2018-2023 ($)
Table 31: Remicade Biosimilar Market By Service, Revenue & Volume, By Clinical Trials, 2018-2023 ($)
Table 32: Remicade Biosimilar Market, Revenue & Volume, By Technology, 2018-2023 ($)
Table 33: Remicade Biosimilar Market By Technology, Revenue & Volume, By Monoclonal Antibodies (MAb) Technology, 2018-2023 ($)
Table 34: Remicade Biosimilar Market By Technology, Revenue & Volume, By Recombinant DNA Technology (rDNA Technology), 2018-2023 ($)
Table 35: Remicade Biosimilar Market By Technology, Revenue & Volume, By Nuclear magnetic resonance (NMR) Technology, 2018-2023 ($)
Table 36: Remicade Biosimilar Market By Technology, Revenue & Volume, By Chromatography, 2018-2023 ($)
Table 37: Remicade Biosimilar Market By Technology, Revenue & Volume, By Electrophoresis, 2018-2023 ($)
Table 38: Remicade Biosimilar Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 39: Remicade Biosimilar Market By Application, Revenue & Volume, By Blood Disorders, 2018-2023 ($)
Table 40: Remicade Biosimilar Market By Application, Revenue & Volume, By Oncology Diseases, 2018-2023 ($)
Table 41: Remicade Biosimilar Market By Application, Revenue & Volume, By Chronic and Autoimmune Diseases, 2018-2023 ($)
Table 42: Remicade Biosimilar Market By Application, Revenue & Volume, By Growth Hormone Deficiencies, 2018-2023 ($)
Table 43: North America Remicade Biosimilar Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 44: North America Remicade Biosimilar Market, Revenue & Volume, By Service, 2018-2023 ($)
Table 45: North America Remicade Biosimilar Market, Revenue & Volume, By Technology, 2018-2023 ($)
Table 46: North America Remicade Biosimilar Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 47: South america Remicade Biosimilar Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 48: South america Remicade Biosimilar Market, Revenue & Volume, By Service, 2018-2023 ($)
Table 49: South america Remicade Biosimilar Market, Revenue & Volume, By Technology, 2018-2023 ($)
Table 50: South america Remicade Biosimilar Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 51: Europe Remicade Biosimilar Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 52: Europe Remicade Biosimilar Market, Revenue & Volume, By Service, 2018-2023 ($)
Table 53: Europe Remicade Biosimilar Market, Revenue & Volume, By Technology, 2018-2023 ($)
Table 54: Europe Remicade Biosimilar Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 55: APAC Remicade Biosimilar Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 56: APAC Remicade Biosimilar Market, Revenue & Volume, By Service, 2018-2023 ($)
Table 57: APAC Remicade Biosimilar Market, Revenue & Volume, By Technology, 2018-2023 ($)
Table 58: APAC Remicade Biosimilar Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 59: Middle East & Africa Remicade Biosimilar Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 60: Middle East & Africa Remicade Biosimilar Market, Revenue & Volume, By Service, 2018-2023 ($)
Table 61: Middle East & Africa Remicade Biosimilar Market, Revenue & Volume, By Technology, 2018-2023 ($)
Table 62: Middle East & Africa Remicade Biosimilar Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 63: Russia Remicade Biosimilar Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 64: Russia Remicade Biosimilar Market, Revenue & Volume, By Service, 2018-2023 ($)
Table 65: Russia Remicade Biosimilar Market, Revenue & Volume, By Technology, 2018-2023 ($)
Table 66: Russia Remicade Biosimilar Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 67: Israel Remicade Biosimilar Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 68: Israel Remicade Biosimilar Market, Revenue & Volume, By Service, 2018-2023 ($)
Table 69: Israel Remicade Biosimilar Market, Revenue & Volume, By Technology, 2018-2023 ($)
Table 70: Israel Remicade Biosimilar Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 71: Top Companies 2017 (US$)Remicade Biosimilar Market, Revenue & Volume
Table 72: Product Launch 2017-2018Remicade Biosimilar Market, Revenue & Volume
Table 73: Mergers & Acquistions 2017-2018Remicade Biosimilar Market, Revenue & Volume


List of Figures:

Figure 1: Overview of Remicade Biosimilar Market 2017-2023
Figure 2: Market Share Analysis for Remicade Biosimilar Market 2017 (US$)
Figure 3: Product Comparison in Remicade Biosimilar Market 2017-2018 (US$)
Figure 4: End User Profile for Remicade Biosimilar Market 2017-2018 (US$)
Figure 5: Patent Application and Grant in Remicade Biosimilar Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Remicade Biosimilar Market 2017-2018 (US$)
Figure 7: Market Entry Strategy in Remicade Biosimilar Market 2017-2018
Figure 8: Ecosystem Analysis in Remicade Biosimilar Market 2017
Figure 9: Average Selling Price in Remicade Biosimilar Market 2017-2023
Figure 10: Top Opportunites in Remicade Biosimilar Market 2017-2018
Figure 11: Market Life Cycle Analysis in Remicade Biosimilar Market Market Life Cycle Analysis in 3D Printing
Figure 12: GlobalBy TypeRemicade Biosimilar Market Revenue, 2018-2023 ($)
Figure 13: GlobalBy ServiceRemicade Biosimilar Market Revenue, 2018-2023 ($)
Figure 14: GlobalBy TechnologyRemicade Biosimilar Market Revenue, 2018-2023 ($)
Figure 15: GlobalBy ApplicationRemicade Biosimilar Market Revenue, 2018-2023 ($)
Figure 16: Global Remicade Biosimilar Market - By Geography
Figure 17: Global Remicade Biosimilar Market Value & Volume, By Geography, 2018-2023 ($) 
Figure 18: Global Remicade Biosimilar Market CAGR, By Geography, 2018-2023 (%)
Figure 19: North America Remicade Biosimilar Market Value & Volume, 2018-2023 ($)
Figure 20: US Remicade Biosimilar Market Value & Volume, 2018-2023 ($)
Figure 21: US GDP and Population, 2017-2018 ($)
Figure 22: US GDP – Composition of 2017, By Sector of Origin
Figure 23: US Export and Import Value & Volume, 2017-2018 ($)
Figure 24: Canada Remicade Biosimilar Market Value & Volume, 2018-2023 ($)
Figure 25: Canada GDP and Population, 2017-2018 ($)
Figure 26: Canada GDP – Composition of 2017, By Sector of Origin
Figure 27: Canada Export and Import Value & Volume, 2017-2018 ($)
Figure 28: Mexico Remicade Biosimilar Market Value & Volume, 2018-2023 ($)
Figure 29: Mexico GDP and Population, 2017-2018 ($)
Figure 30: Mexico GDP – Composition of 2017, By Sector of Origin
Figure 31: Mexico Export and Import Value & Volume, 2017-2018 ($)
Figure 32: South America Remicade Biosimilar Market South America 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 33: Brazil Remicade Biosimilar Market Value & Volume, 2018-2023 ($)
Figure 34: Brazil GDP and Population, 2017-2018 ($)
Figure 35: Brazil GDP – Composition of 2017, By Sector of Origin
Figure 36: Brazil Export and Import Value & Volume, 2017-2018 ($)
Figure 37: Venezuela Remicade Biosimilar Market Value & Volume, 2018-2023 ($)
Figure 38: Venezuela GDP and Population, 2017-2018 ($)
Figure 39: Venezuela GDP – Composition of 2017, By Sector of Origin
Figure 40: Venezuela Export and Import Value & Volume, 2017-2018 ($)
Figure 41: Argentina Remicade Biosimilar Market Value & Volume, 2018-2023 ($)
Figure 42: Argentina GDP and Population, 2017-2018 ($)
Figure 43: Argentina GDP – Composition of 2017, By Sector of Origin
Figure 44: Argentina Export and Import Value & Volume, 2017-2018 ($)
Figure 45: Ecuador Remicade Biosimilar Market Value & Volume, 2018-2023 ($)
Figure 46: Ecuador GDP and Population, 2017-2018 ($)
Figure 47: Ecuador GDP – Composition of 2017, By Sector of Origin
Figure 48: Ecuador Export and Import Value & Volume, 2017-2018 ($)
Figure 49: Peru Remicade Biosimilar Market Value & Volume, 2018-2023 ($)
Figure 50: Peru GDP and Population, 2017-2018 ($)
Figure 51: Peru GDP – Composition of 2017, By Sector of Origin
Figure 52: Peru Export and Import Value & Volume, 2017-2018 ($)
Figure 53: Colombia Remicade Biosimilar Market Value & Volume, 2018-2023 ($)
Figure 54: Colombia GDP and Population, 2017-2018 ($)
Figure 55: Colombia GDP – Composition of 2017, By Sector of Origin
Figure 56: Colombia Export and Import Value & Volume, 2017-2018 ($)
Figure 57: Costa Rica Remicade Biosimilar Market Costa Rica 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 58: Costa Rica GDP and Population, 2017-2018 ($)
Figure 59: Costa Rica GDP – Composition of 2017, By Sector of Origin
Figure 60: Costa Rica Export and Import Value & Volume, 2017-2018 ($)
Figure 61: Europe Remicade Biosimilar Market Value & Volume, 2018-2023 ($)
Figure 62: U.K Remicade Biosimilar Market Value & Volume, 2018-2023 ($)
Figure 63: U.K GDP and Population, 2017-2018 ($)
Figure 64: U.K GDP – Composition of 2017, By Sector of Origin
Figure 65: U.K Export and Import Value & Volume, 2017-2018 ($)
Figure 66: Germany Remicade Biosimilar Market Value & Volume, 2018-2023 ($)
Figure 67: Germany GDP and Population, 2017-2018 ($)
Figure 68: Germany GDP – Composition of 2017, By Sector of Origin
Figure 69: Germany Export and Import Value & Volume, 2017-2018 ($)
Figure 70: Italy Remicade Biosimilar Market Value & Volume, 2018-2023 ($)
Figure 71: Italy GDP and Population, 2017-2018 ($)
Figure 72: Italy GDP – Composition of 2017, By Sector of Origin
Figure 73: Italy Export and Import Value & Volume, 2017-2018 ($)
Figure 74: France Remicade Biosimilar Market Value & Volume, 2018-2023 ($)
Figure 75: France GDP and Population, 2017-2018 ($)
Figure 76: France GDP – Composition of 2017, By Sector of Origin
Figure 77: France Export and Import Value & Volume, 2017-2018 ($)
Figure 78: Netherlands Remicade Biosimilar Market Value & Volume, 2018-2023 ($)
Figure 79: Netherlands GDP and Population, 2017-2018 ($)
Figure 80: Netherlands GDP – Composition of 2017, By Sector of Origin
Figure 81: Netherlands Export and Import Value & Volume, 2017-2018 ($)
Figure 82: Belgium Remicade Biosimilar Market Value & Volume, 2018-2023 ($)
Figure 83: Belgium GDP and Population, 2017-2018 ($)
Figure 84: Belgium GDP – Composition of 2017, By Sector of Origin
Figure 85: Belgium Export and Import Value & Volume, 2017-2018 ($)
Figure 86: Spain Remicade Biosimilar Market Value & Volume, 2018-2023 ($)
Figure 87: Spain GDP and Population, 2017-2018 ($)
Figure 88: Spain GDP – Composition of 2017, By Sector of Origin
Figure 89: Spain Export and Import Value & Volume, 2017-2018 ($)
Figure 90: Denmark Remicade Biosimilar Market Value & Volume, 2018-2023 ($)
Figure 91: Denmark GDP and Population, 2017-2018 ($)
Figure 92: Denmark GDP – Composition of 2017, By Sector of Origin
Figure 93: Denmark Export and Import Value & Volume, 2017-2018 ($)
Figure 94: APAC Remicade Biosimilar Market Value & Volume, 2018-2023 ($)
Figure 95: China Remicade Biosimilar Market Value & Volume, 2018-2023
Figure 96: China GDP and Population, 2017-2018 ($)
Figure 97: China GDP – Composition of 2017, By Sector of Origin
Figure 98: China Export and Import Value & Volume, 2017-2018 ($)Remicade Biosimilar Market China Export and Import Value & Volume, 2017-2018 ($)
Figure 99: Australia Remicade Biosimilar Market Value & Volume, 2018-2023 ($)
Figure 100: Australia GDP and Population, 2017-2018 ($)
Figure 101: Australia GDP – Composition of 2017, By Sector of Origin
Figure 102: Australia Export and Import Value & Volume, 2017-2018 ($)
Figure 103: South Korea Remicade Biosimilar Market Value & Volume, 2018-2023 ($)
Figure 104: South Korea GDP and Population, 2017-2018 ($)
Figure 105: South Korea GDP – Composition of 2017, By Sector of Origin
Figure 106: South Korea Export and Import Value & Volume, 2017-2018 ($)
Figure 107: India Remicade Biosimilar Market Value & Volume, 2018-2023 ($)
Figure 108: India GDP and Population, 2017-2018 ($)
Figure 109: India GDP – Composition of 2017, By Sector of Origin
Figure 110: India Export and Import Value & Volume, 2017-2018 ($)
Figure 111: Taiwan Remicade Biosimilar Market Taiwan 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 112: Taiwan GDP and Population, 2017-2018 ($)
Figure 113: Taiwan GDP – Composition of 2017, By Sector of Origin
Figure 114: Taiwan Export and Import Value & Volume, 2017-2018 ($)
Figure 115: Malaysia Remicade Biosimilar Market Malaysia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 116: Malaysia GDP and Population, 2017-2018 ($)
Figure 117: Malaysia GDP – Composition of 2017, By Sector of Origin
Figure 118: Malaysia Export and Import Value & Volume, 2017-2018 ($)
Figure 119: Hong Kong Remicade Biosimilar Market Hong Kong 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 120: Hong Kong GDP and Population, 2017-2018 ($)
Figure 121: Hong Kong GDP – Composition of 2017, By Sector of Origin
Figure 122: Hong Kong Export and Import Value & Volume, 2017-2018 ($)
Figure 123: Middle East & Africa Remicade Biosimilar Market Middle East & Africa 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 124: Russia Remicade Biosimilar Market Russia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 125: Russia GDP and Population, 2017-2018 ($)
Figure 126: Russia GDP – Composition of 2017, By Sector of Origin
Figure 127: Russia Export and Import Value & Volume, 2017-2018 ($)
Figure 128: Israel Remicade Biosimilar Market Value & Volume, 2018-2023 ($)
Figure 129: Israel GDP and Population, 2017-2018 ($)
Figure 130: Israel GDP – Composition of 2017, By Sector of Origin
Figure 131: Israel Export and Import Value & Volume, 2017-2018 ($)
Figure 132: Entropy Share, By Strategies, 2017-2018* (%)Remicade Biosimilar Market
Figure 133: Developments, 2017-2018*Remicade Biosimilar Market
Figure 134: Company 1 Remicade Biosimilar Market Net Revenue, By Years, 2017-2018* ($)
Figure 135: Company 1 Remicade Biosimilar Market Net Revenue Share, By Business segments, 2017 (%)
Figure 136: Company 1 Remicade Biosimilar Market Net Sales Share, By Geography, 2017 (%)
Figure 137: Company 2 Remicade Biosimilar Market Net Revenue, By Years, 2017-2018* ($)
Figure 138: Company 2 Remicade Biosimilar Market Net Revenue Share, By Business segments, 2017 (%)
Figure 139: Company 2 Remicade Biosimilar Market Net Sales Share, By Geography, 2017 (%)
Figure 140: Company 3 Remicade Biosimilar Market Net Revenue, By Years, 2017-2018* ($)
Figure 141: Company 3 Remicade Biosimilar Market Net Revenue Share, By Business segments, 2017 (%)
Figure 142: Company 3 Remicade Biosimilar Market Net Sales Share, By Geography, 2017 (%)
Figure 143: Company 4 Remicade Biosimilar Market Net Revenue, By Years, 2017-2018* ($)
Figure 144: Company 4 Remicade Biosimilar Market Net Revenue Share, By Business segments, 2017 (%)
Figure 145: Company 4 Remicade Biosimilar Market Net Sales Share, By Geography, 2017 (%)
Figure 146: Company 5 Remicade Biosimilar Market Net Revenue, By Years, 2017-2018* ($)
Figure 147: Company 5 Remicade Biosimilar Market Net Revenue Share, By Business segments, 2017 (%)
Figure 148: Company 5 Remicade Biosimilar Market Net Sales Share, By Geography, 2017 (%)
Figure 149: Company 6 Remicade Biosimilar Market Net Revenue, By Years, 2017-2018* ($)
Figure 150: Company 6 Remicade Biosimilar Market Net Revenue Share, By Business segments, 2017 (%)
Figure 151: Company 6 Remicade Biosimilar Market Net Sales Share, By Geography, 2017 (%)
Figure 152: Company 7 Remicade Biosimilar Market Net Revenue, By Years, 2017-2018* ($)
Figure 153: Company 7 Remicade Biosimilar Market Net Revenue Share, By Business segments, 2017 (%)
Figure 154: Company 7 Remicade Biosimilar Market Net Sales Share, By Geography, 2017 (%)
Figure 155: Company 8 Remicade Biosimilar Market Net Revenue, By Years, 2017-2018* ($)
Figure 156: Company 8 Remicade Biosimilar Market Net Revenue Share, By Business segments, 2017 (%)
Figure 157: Company 8 Remicade Biosimilar Market Net Sales Share, By Geography, 2017 (%)
Figure 158: Company 9 Remicade Biosimilar Market Net Revenue, By Years, 2017-2018* ($)
Figure 159: Company 9 Remicade Biosimilar Market Net Revenue Share, By Business segments, 2017 (%)
Figure 160: Company 9 Remicade Biosimilar Market Net Sales Share, By Geography, 2017 (%)
Figure 161: Company 10 Remicade Biosimilar Market Net Revenue, By Years, 2017-2018* ($)
Figure 162: Company 10 Remicade Biosimilar Market Net Revenue Share, By Business segments, 2017 (%)
Figure 163: Company 10 Remicade Biosimilar Market Net Sales Share, By Geography, 2017 (%)
Figure 164: Company 11 Remicade Biosimilar Market Net Revenue, By Years, 2017-2018* ($)
Figure 165: Company 11 Remicade Biosimilar Market Net Revenue Share, By Business segments, 2017 (%)
Figure 166: Company 11 Remicade Biosimilar Market Net Sales Share, By Geography, 2017 (%)
Figure 167: Company 12 Remicade Biosimilar Market Net Revenue, By Years, 2017-2018* ($)
Figure 168: Company 12 Remicade Biosimilar Market Net Revenue Share, By Business segments, 2017 (%)
Figure 169: Company 12 Remicade Biosimilar Market Net Sales Share, By Geography, 2017 (%)
Figure 170: Company 13 Remicade Biosimilar Market Net Revenue, By Years, 2017-2018* ($)
Figure 171: Company 13 Remicade Biosimilar Market Net Revenue Share, By Business segments, 2017 (%)
Figure 172: Company 13 Remicade Biosimilar Market Net Sales Share, By Geography, 2017 (%)
Figure 173: Company 14 Remicade Biosimilar Market Net Revenue, By Years, 2017-2018* ($)
Figure 174: Company 14 Remicade Biosimilar Market Net Revenue Share, By Business segments, 2017 (%)
Figure 175: Company 14 Remicade Biosimilar Market Net Sales Share, By Geography, 2017 (%)
Figure 176: Company 15 Remicade Biosimilar Market Net Revenue, By Years, 2017-2018* ($)
Figure 177: Company 15 Remicade Biosimilar Market Net Revenue Share, By Business segments, 2017 (%)
Figure 178: Company 15 Remicade Biosimilar Market Net Sales Share, By Geography, 2017 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll